Energy & Nutrition

RenovoRx is a life sciences company dedicated to developing innovative targeted oncology therapies, focusing on addressing high unmet medical needs in cancer treatment. Their flagship product, RenovoCath, is an FDA-cleared drug-delivery device designed to enhance the intra-arterial administration of chemotherapy, specifically targeting locally advanced pancreatic cancer. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform aims to improve the effectiveness and safety of cancer therapies by delivering treatment directly to tumor sites while minimizing systemic side effects. Currently, RenovoRx is conducting a Phase III clinical trial, TIGeR-PaC, to evaluate the efficacy of its combination oncology product candidate against standard intravenous chemotherapy options. Generated from the website

Central Admixture Pharmacy Services (CAPS) is the largest network of outsourcing admixture pharmacies in the United States, specializing in 503A and 503B compounded sterile preparations (CSPs). With a commitment to high-quality medications and patient safety, CAPS operates 21 regional pharmacies and two FDA-registered outsourcing facilities to meet customized and non-patient-specific compounding needs. Focused on improving operational efficiency, CAPS offers innovative solutions like the CAPSLink PN Ordering Software to reduce transcription errors and streamline order entry processes. The company prioritizes quality assurance through its cGMP Level Release Testing and comprehensive compliance program, ensuring reliable access to essential medications for patients. Generated from the website